David J. Clark
Overview
David J. Clark received an average of $596K in total compensation, including $267K in salary, at Trevi Therapeutics between 2022 and 2023. David Clark also received an average of $1M at Aldeyra Therapeutics from 2016 to 2019.
Source: SEC filings on April 26, 2024, April 27, 2020, April 22, 2019, April 25, 2018, and April 24, 2017.
Related executives
We found ten more executives who work or worked at Trevi Therapeutics and Aldeyra Therapeutics.
Todd Brady
Aldeyra Therapeutics
Chief Executive Officer
Jennifer Good
Trevi Therapeutics
Chief Executive Officer
Stephen Machatha
Aldeyra Therapeutics
Chief Development Officer
Thomas Sciascia
Trevi Therapeutics
Chief Scientific Officer
Bruce Greenberg
Aldeyra Therapeutics
Chief Financial Officer
Joshua Reed
Aldeyra Therapeutics
Chief Financial Officer
Yann Mazabraud
Trevi Therapeutics
Chief Commercial Officer and Head of International
David McMullin
Aldeyra Therapeutics